Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Ragonese

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
Brain Sciences|April 3, 2021
FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple SclerosisConcetta Scazzone, Luisa Agnello, Bruna Lo Sasso, et al.
Scientific Reports|July 13, 2024
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patientsAlessandra Amato, Patrizia Proia, Anna Alioto, et al.
Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 16, 2025
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patientsClara G Chisari, Salvatore Lo Fermo, Salvatore Iacono, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 12, 2014
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter studyGiovanni Frisullo, Massimiliano Calabrese, Carla Tortorella, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 20, 2025
The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseasesLuisa Agnello, Caterina Maria Gambino, Anna Maria Ciaccio, et al.
Parkinsonism & Related Disorders|March 10, 2007
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaireLetterio Morgante, Francesca Morgante, Elena Moro, et al.
Journal of Neurology|February 21, 2024
A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological researchVasco Ribeiro Ferreira, Carol Brayne, Paolo Ragonese, et al.
Neuroepidemiology|January 24, 2004
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studiesPaolo Ragonese, Graziella Filippini, Giuseppe Salemi, et al.
Annals of Neurology|October 22, 2005
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complexGrazia Annesi, Giovanni Savettieri, Pierfrancesco Pugliese, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Brain Sciences|April 3, 2021
FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple SclerosisConcetta Scazzone, Luisa Agnello, Bruna Lo Sasso, et al.
Scientific Reports|July 13, 2024
High-intensity interval training improves bone remodeling, lipid profile, and physical function in multiple sclerosis patientsAlessandra Amato, Patrizia Proia, Anna Alioto, et al.
Transfusion|June 26, 2010
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximabDomenica Caramazza, Gerlando Quintini, Ignazio Abbene, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|September 16, 2025
Real-world effectiveness and safety of ofatumumab in relapsing-remitting multiple sclerosis: Insights from naïve and switch patientsClara G Chisari, Salvatore Lo Fermo, Salvatore Iacono, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 12, 2014
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter studyGiovanni Frisullo, Massimiliano Calabrese, Carla Tortorella, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 20, 2025
The value of serum glial fibrillary acidic protein as a biomarker of astrogliosis in different neurological diseasesLuisa Agnello, Caterina Maria Gambino, Anna Maria Ciaccio, et al.
Parkinsonism & Related Disorders|March 10, 2007
How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? Results of a questionnaireLetterio Morgante, Francesca Morgante, Elena Moro, et al.
Journal of Neurology|February 21, 2024
A Delphi consensus to identify the key screening tests/questions for a digital neurological examination for epidemiological researchVasco Ribeiro Ferreira, Carol Brayne, Paolo Ragonese, et al.
Neuroepidemiology|January 24, 2004
Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studiesPaolo Ragonese, Graziella Filippini, Giuseppe Salemi, et al.
Annals of Neurology|October 22, 2005
DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complexGrazia Annesi, Giovanni Savettieri, Pierfrancesco Pugliese, et al.
Pageof 11